J Int Med Res 2021;49:03000605211067125
Depending on tolerance and individual response, the dosage may be changed
A starting dose of 1 mg or 1.5 mg, while not part of the standard branded protocol, allows the body to acclimate more gradually
For protocols that value regulatory-grade evidence depth and a settled safety label, tirzepatide remains the reference molecule
doi: 10.3168/jds.2019-16840 Summary Keywords ulcerative colitis, Caco-2, Lactobacillus fermentum , metabolites, gut microbiota Citation Su L, Ma F, An Z, Ji X, Zhang P, Yue Q, Zhao C, Sun X, Li K, Li B, Liu X and Zhao L (2022) The Metabolites of Lactobacillus fermentum F-B9-1 Relieved Dextran Sulfate Sodium-Induced Experimental Ulcerative Colitis in Mice
Survodutide is also being studied in Phase 3 trials for the treatment of MASH